Compounded GLP-1 Alternatives — April 2026 Verified Guide
Compounded GLP-1 Alternatives (2026): Every Option With Real Prices
Bottom Line — April 2026
Best overall compounded option (cash-pay, no insurance): MEDVi — $179 first month, $299/month ongoing, everything included, no membership fee. Over 100,000 patients, LegitScript certified, money-back weight-loss guarantee.
Best FDA-approved pill (no needles, no membership): Foundayo — $149/month self-pay at starting dose. FDA-approved April 1, 2026. Take any time of day, no food or water restrictions.
Best if you have insurance or want to try: Ro — insurance concierge checks coverage and handles prior authorization. Membership $45 first month, $149/month ongoing. Medication billed separately.
Tightest budget, compounded fallback: Yucca Health — $146/month on a 6-month plan. Clear disclosure, 24/7 support, only charged if approved.
FDA resolved the semaglutide shortage in February 2025 and sent 30 warning letters to telehealth companies in March 2026 for misleading compounded GLP-1 marketing. The mass-marketed compounded era is narrowing. But affordable treatment didn’t disappear — it shifted.
The rest of this page walks through every viable path — FDA-approved and compounded — with verified pricing, honest tradeoffs, and the specific next step for your situation. We also built a side-by-side matrix combining real pricing, hidden membership math, FDA status, and trust signals across every major option. That combination doesn’t exist on any other single page.
Best Compounded GLP-1 Alternatives at a Glance (April 2026)
Every price below was verified directly from provider websites and manufacturer pricing pages during the week of April 7, 2026. Where a provider advertises a “starting at” price that excludes membership fees or requires a long-term commitment, we flag it.
| Option | Type | Month-1 All-In | Ongoing Cost | Oral Option? | Insurance Help? | Best For |
|---|---|---|---|---|---|---|
| MEDVi | Compounded | $179 (all-in) | $299/mo all-in | Tablets from $249 | ❌ | Cash-pay, no membership, fastest start |
| Foundayo | FDA-approved | $149 (0.8 mg) | $149–$299/mo by dose | ✅ Pill only | $25/mo if insured | No needles, FDA-approved, clean pricing |
| Wegovy Pill | FDA-approved | $149 (1.5 mg) | $149–$299/mo by dose† | ✅ Pill only | Savings card available | Most clinical data, established efficacy |
| Ro | FDA-approved | $194 ($45 + $149 med) | $149 membership + med‡ | ✅ Wegovy pill access | ✅ Full concierge | Insurance navigation, brand-name certainty |
| Zepbound | FDA-approved | $299 (2.5 mg) | $399–$449/mo** | ❌ | Savings card available | Maximum weight loss (20%+ in trials) |
| Eden | Compounded | $129–$149 | $249/mo flat rate | Yes | ❌ | Flat-rate dosing, explicit clinical disclosure |
| Yucca Health | Compounded | $146 (6-mo plan) | $175/mo (monthly) | Injectable | ❌ | Tightest possible budget |
†Wegovy Pill 4 mg at $149/mo available through August 31, 2026 only; becomes $199/mo after. ‡Ro membership and medication billed separately. Cash-pay medication starts at $149/mo. **Zepbound higher-dose discount requires refill within 45 days.
Sources verified April 7–9, 2026: medvi.io, foundayo.lilly.com, wegovy.com, ro.co, zepbound.lilly.com, tryeden.com, tryyucca.com
Why Is Everyone Looking for Compounded GLP-1 Alternatives Right Now?
The compounded GLP-1 market didn’t collapse overnight. It shifted over 18 months, and most people are just now feeling the effects. Here’s the timeline that matters:
December 19, 2024
FDA resolved the tirzepatide (Mounjaro/Zepbound) shortage. The legal basis for bulk 503B compounding of tirzepatide effectively ended. (FDA.gov)
February 21, 2025
FDA resolved the semaglutide (Ozempic/Wegovy) shortage. Same effect for semaglutide. (FDA.gov)
February 6, 2026
FDA announced intention to take "decisive enforcement action" against non-FDA-approved compounded GLP-1 drugs. (FDA.gov)
March 3, 2026
FDA sent 30 warning letters to telehealth companies for false or misleading compounded GLP-1 claims — including claims that compounded products were equivalent to FDA-approved drugs. (FDA.gov)
April 1, 2026
Foundayo (orforglipron), Eli Lilly's oral GLP-1 pill, received FDA approval. Shipping started April 6 via LillyDirect at $149/month self-pay. (FDA.gov)
What this means for you: Compounded GLP-1s are not fully gone. 503A pharmacies can still compound semaglutide and tirzepatide when a prescriber documents a patient-specific clinical need. Several reputable telehealth providers continue operating through this pathway. But the era of mass-marketed compounded GLP-1s is narrowing — and the providers that survive will be the ones with honest disclosure and legitimate pharmacy partnerships.
Meanwhile, FDA-approved alternatives got dramatically cheaper. The Wegovy pill launched at $149/month. Foundayo launched at $149/month. Zepbound self-pay starts at $299/month. The price gap between compounded and FDA-approved has shrunk to the smallest it’s ever been.
Which Path Actually Fits Your Situation?
Not your provider preference. Not which brand is running the most ads. Your situation — insurance status, budget, needle tolerance, and how much regulatory certainty matters to you.
If you’re paying cash and want the most affordable all-in option → MEDVi
Compounded semaglutide injections: $179 first month, $299/month ongoing. Compounded tirzepatide: $279 first month, $399/month ongoing. Oral tablets available from $249/month. That $299/month includes everything — physician evaluation, medication, shipping in temperature-controlled packaging, 24/7 unlimited provider messaging, and dose adjustments at no extra charge. No membership fee. No contract.
MEDVi is LegitScript certified. Over 100,000 patients. 4.4/5 Trustpilot from more than 11,000 reviews. They offer a money-back weight-loss guarantee — if you follow the protocol for five months and don’t lose weight, you’re eligible for a refund minus a 25% consultation fee.
“Medvi was not my first choice but is my last. The first two programs I tried turned me down. Medvi accepted me, and I am 31 pounds down — a size 12/14 for the first time in over 15 years.” — Verified ConsumerAffairs review
If you want FDA-approved medication and no needles → Foundayo or Wegovy Pill
Foundayo (orforglipron) — starting at $149/month, launched April 2026
Eli Lilly’s once-daily oral GLP-1 pill — FDA-approved April 1, 2026. Take it any time of day, with or without food, with no water restrictions. The Wegovy pill, by contrast, must be taken on an empty stomach with no more than 4 oz of water and a 30-minute fast. For people who’ve struggled with complicated dosing routines, Foundayo removes that friction entirely.
| Foundayo Dose | Monthly Self-Pay Price | Note |
|---|---|---|
| 0.8 mg (starting) | $149 | |
| 2.5 mg | $199 | |
| 5.5 mg | $299 | |
| 9 mg | $299 | |
| 14.5 mg | $299 | Must refill within 45 days or becomes $349 |
| 17.2 mg | $299 | Must refill within 45 days or becomes $349 |
Commercially insured with coverage: as low as $25/month. Medicare Part D: ~$50/month beginning July 1, 2026. Source: foundayo.lilly.com
In clinical trials (ATTAIN-1), participants who completed treatment at the highest dose lost an average of 12.4% body weight (~27 pounds) over 72 weeks. That’s lower than injectable semaglutide (~15%) or tirzepatide (~21%) in their trials — the tradeoff is a pill, FDA-approved, and priced at $149/month. (FDA approval announcement)
Wegovy Pill — starting at $149/month
The original oral semaglutide for weight loss. FDA-approved, proven efficacy (up to 17% body weight loss at highest dose in trials). Must be taken on an empty stomach with no more than 4 oz of water, then wait 30 minutes before eating or drinking. Most clinical data of any oral option.
| Wegovy Pill Dose | Monthly Self-Pay Price | Note |
|---|---|---|
| 1.5 mg (starting) | $149 | |
| 4 mg | $149 | Through August 31, 2026 only — becomes $199 after |
| 9 mg, 25 mg | ~$299 | Per Ro’s cash-pay Wegovy pages |
If you want the easiest daily routine, Foundayo wins. If you want the most clinical data behind your pill, Wegovy has years of STEP trial results. For a full comparison: Orforglipron vs Wegovy Pill →
If you have commercial insurance (or want to try) → Ro
Ro’s insurance concierge does the work of checking your coverage, filing prior authorizations, and handling appeals. If your insurance covers GLP-1 medication and you stack a manufacturer savings card, your medication copay could drop to as low as $25/month.
| Ro Cost Component | Price |
|---|---|
| Membership (month 1) | $45 |
| Membership (ongoing monthly plan) | $149/mo |
| Membership (annual prepay) | As low as $74/mo |
| Cash-pay medication (lowest dose pill) | From $149/mo |
| If insurance covers medication + savings card | As low as $25/mo copay |
The honest math: If you end up paying cash for both the membership and medication, Ro is more expensive than going direct to LillyDirect or NovoCare, or using MEDVi for compounded access. Ro’s value is in the insurance help. If you already know insurance won’t cover it and want the lowest possible cash-pay price, the direct options or compounded providers will cost less.
“Ro was easy to get started — meds are shipped within a week.” — Trustpilot review
For the full breakdown: Best GLP-1 Providers That Accept Insurance →
If you want the strongest possible weight loss results → Zepbound
Tirzepatide is a dual GIP/GLP-1 receptor agonist. In clinical trials, it produced 20–25% average body weight loss at the highest dose — substantially more than semaglutide alone. Despite producing more weight loss, clinical data show lower rates of nausea and vomiting than semaglutide. Researchers believe GIP activation may counterbalance some GLP-1-related gut effects.
- 2.5 mg: $299/month
- 5 mg: $399/month
- Higher doses: $449/month (drops to $299 with refill within 45 days on qualifying doses)
Source: zepbound.lilly.com/savings
Check Zepbound pricing on LillyDirect ↗If your budget is under $200/month and compounded is the only way
Compounded options still exist — but you need to pick carefully. Here’s where we’d look.
Yucca Health — $146/month on a 6-month plan
The tightest-budget compounded option with clear disclosure. 6-month plan: $146/month. Month-to-month: $175 first month. Only charged if approved. 24/7 support, cancel anytime.
“The sign up process was fast and easy. I feel confident that I made the right choice.” — Yucca verified patient
The $146 price requires a 6-month commitment. Month-to-month is higher. As with all compounded options, the medication is not FDA-approved as a finished product.
Check Yucca pricing and see if you qualify ↗Eden — First month as low as $129, ongoing $249/month flat rate
Eden stands out for explicit clinical disclosure — its site states compounded GLP-1 medication is only prepared when a prescriber determines a “clinically significant difference” for an individual patient. Flat-rate pricing that doesn’t increase when your dose goes up. Board-certified physicians write all prescriptions. Licensed 503A pharmacy network with third-party testing.
“Doctors are knowledgeable, responsive and very careful with details.” — Eden Trustpilot reviewSee Eden’s flat-rate pricing and qualification criteria ↗
TrimRx — $199/month all-inclusive
Simple, all-inclusive pricing. No extras. Straightforward. Read the cancellation terms carefully before committing to any plan longer than month-to-month.
See TrimRx pricing ↗What These Options Really Cost Over 6 Months
Single-month pricing is misleading. GLP-1 treatment is a long-term commitment — most people stay on medication for 6–12+ months. Here’s what each path actually costs over a realistic timeline, built from verified pricing as of April 9, 2026.
| Path | Month 1 | Months 2–6 | 6-Mo Total | 12-Mo Total | Key Note |
|---|---|---|---|---|---|
| MEDVi (comp. sema.) | $179 | $299 × 5 | $1,674 | $3,468 | All-in, no dose surcharges |
| Foundayo (0.8 mg) | $149 | $149 × 5 | $894 | $1,788 | Higher doses increase to $199–$299 |
| Wegovy Pill (1.5 mg) | $149 | $149 × 5 | $894 | $1,788 | 4 mg stays $149 only through Aug 31, 2026 |
| Ro (cash-pay + pill) | $194 | ~$298 × 5 | $1,684 | $3,522 | Insurance drops cost significantly |
| Zepbound (2.5 mg) | $299 | $299–$449 × 5 | $1,794–$2,544 | $3,588–$5,088 | 45-day refill window for discount |
| Yucca (6-mo plan) | $146 | $146 × 5 | $876 | $1,752 | Requires 6-month commitment upfront |
| Eden (compounded) | $129–$149 | $249 × 5 | $1,374–$1,394 | $2,838 | Flat rate — no dose increase surcharges |
The insight this table reveals
Foundayo at the starting dose and Yucca on the 6-month plan are the two cheapest 6-month paths in the entire market right now — and they’re on opposite ends of the FDA-approval spectrum. Your choice between them is really a choice about how much regulatory certainty matters to you versus how tight your budget is.
Compounded vs. FDA-Approved: The Real Tradeoffs
What “not FDA-approved” actually means
Compounded GLP-1 medications are prepared by state-licensed pharmacies based on a valid prescription from a licensed clinician. The FDA does not review the finished compounded product for safety, effectiveness, or quality before it reaches you. This is fundamentally different from FDA-approved drugs like Wegovy, Zepbound, and Foundayo, which went through multi-year clinical trial programs. (FDA: Concerns with Unapproved GLP-1 Drugs)
What it does NOT mean
“Not FDA-approved” does not mean unregulated. 503A compounding pharmacies operate under state board of pharmacy oversight. Reputable providers use pharmacies that undergo regular inspections and can provide Certificates of Analysis (COA) confirming potency and purity.
Where the real risk sits
The FDA has documented cases of compounded products with incorrect concentrations, contamination, and dosing confusion from vial-based delivery. The agency has received multiple adverse-event reports — including some requiring hospitalization — associated with compounded semaglutide. Many involved dosing errors from vials rather than pre-filled pens used by brand-name products.
Our practical framework
If the price difference is $50/month or less: Choose FDA-approved. Wegovy pill and Foundayo at $149/month have closed the gap at starting doses. The regulatory certainty is worth $50.
If the price difference is $100+/month and you’re financially constrained: Compounded through a reputable provider (MEDVi, Eden, Yucca) remains a legitimate access path for people who would otherwise go without treatment entirely.
If you have commercial insurance: Start with Ro’s insurance concierge. If your insurance covers brand-name GLP-1s, you may pay less than compounded.
Five questions to ask any compounded provider before you pay
- Which pharmacy compounds your medication? Is it a licensed 503A or 503B facility?
- Can you provide a Certificate of Analysis (COA) confirming potency and purity?
- Does the monthly price include everything — consultation, medication, shipping, dose adjustments?
- What’s the cancellation policy? Can I cancel through the portal or must I call?
- Is the provider LegitScript certified?
How to Switch From Compounded to Brand-Name Safely
Step 1: Document your current state
Write down your current compounded medication (semaglutide or tirzepatide), your current dose in milligrams, your injection frequency, and the date of your last injection. Your new prescriber needs this.
Step 2: Decide pill vs. injection
Foundayo: simplest routine, any time of day. Wegovy Pill: most clinical data. Both start at $149/month. If staying with injection: Wegovy injection or Zepbound — pre-filled pens vs. vial-and-syringe, less room for error.
Step 3: Talk to your new prescriber about dose matching
In many cases, your clinician can match your current dose to the closest FDA-approved dose rather than forcing you back to the lowest starting dose. Your prescriber makes this call — don’t guess.
Step 4: Don’t leave a gap
Overlap your compounded supply with your new prescription to avoid interrupting treatment. Clinical evidence shows stopping GLP-1 medication — even briefly — can lead to weight regain and appetite rebound.
Which Providers Can You Actually Trust Right Now?
We checked five things for every provider on this page — because the FDA just warned 30 companies and this is the section most comparison sites skip.
| Provider | Pricing Transparent? | Compounded Clearly Labeled? | FDA Warning Letter? | Pharmacy Named? | Cancel Online? |
|---|---|---|---|---|---|
| MEDVi | ✅ All-in, no membership | ✅ Yes | ⚠️ Feb 2026 (marketing language) | ✅ Named in terms | ✅ Portal/CS, 72 hrs before billing |
| Foundayo/LillyDirect | ✅ Manufacturer direct | ✅ FDA-approved only | N/A | ✅ Lilly-authorized | ✅ |
| Ro | ⚠️ Membership + med billed separately | ✅ Clearly separated | None | ✅ | ✅ |
| Eden | ✅ Flat-rate, no membership | ✅ Explicit clinical disclosure | None | ✅ 503A, third-party tested | ✅ |
| Yucca | ✅ Only charged if approved | ✅ Clear | None | ✅ | ✅ |
| TrimRx | ✅ All-in | ✅ Clear | None | ✅ | ✅ |
Our take: The February 2026 warning letters targeted marketing language — specifically, claims that compounded products were equivalent to FDA-approved drugs. These were advertising issues, not safety recalls. MEDVi updated their website language after receiving their letter.
If a clean regulatory record is non-negotiable for you, the FDA-approved paths (Foundayo, Wegovy Pill, Ro, Zepbound) eliminate that question entirely. Eden and Yucca also have clean records among compounded options.
What If Your Current Program Is Ending This Month?
Today
Document your current dose, medication type, and last injection date. Screenshot your provider dashboard or prescription details.
This week
Decide whether you want to stay compounded or switch to FDA-approved. If you have commercial insurance, check Ro’s coverage tool before doing anything else — you might qualify for brand-name medication at lower total cost than what you’ve been paying.
If you want FDA-approved medication fast
Foundayo prescriptions are being accepted now through LillyDirect with 3–5 day free home shipping. Wegovy pill is also available through NovoCare and most major pharmacies.
If you want to stay compounded
Switch to a provider operating within the 503A patient-specific compounding framework — MEDVi, Eden, or Yucca. Don’t wait until your current supply runs out. Order from the new provider while you still have supply from the old one.
Do NOT do this
Do not buy compounded GLP-1 medication from overseas pharmacies, social media sellers, or websites that don’t require a prescription. The FDA has documented fraudulent compounded products with fake pharmacy labels and incorrect concentrations.
Foundayo vs. Wegovy Pill vs. Compounded Semaglutide: Head-to-Head
This comparison didn’t exist before Foundayo became available in April 2026. Here are the actual numbers side by side.
| Factor | Foundayo | Wegovy Pill | Compounded Sema. (MEDVi) |
|---|---|---|---|
| FDA-approved? | ✅ Yes (April 1, 2026) | ✅ Yes | ❌ Not as a finished product |
| Starting dose price | $149/mo (0.8 mg) | $149/mo (1.5 mg) | $179 first month |
| Mid-range dose price | $299/mo (5.5–9 mg) | $149 (4 mg, thru 8/31/26) | $299/mo (all doses) |
| Highest dose price | $299/mo (with 45-day refill) | ~$299/mo | $299/mo (all doses) |
| Needle-free? | ✅ Daily pill | ✅ Daily pill | ❌ Weekly injection (tablets from $249) |
| Food/water restrictions? | ✅ None — any time | ❌ Empty stomach, 4 oz water, 30-min fast | N/A (injection) |
| Avg weight loss (highest dose, completers) | 12.4% body weight | Up to 17% body weight | *See note |
| Insurance option? | $25/mo with commercial coverage | Savings card available | No |
| Medicare? | ~$50/mo beginning July 2026 | Check plan | No |
*Compounded products have not undergone clinical trials as finished products. The FDA does not review them for safety, effectiveness, or quality. Efficacy estimates for branded semaglutide come from the STEP trial program. Compounded formulations may differ in inactive ingredients, formulation, and delivery method.
The insight nobody else can show yet
At the starting dose, all three cluster around $149–$179/month. The pricing divergence happens at maintenance doses. MEDVi’s flat $299/month regardless of dose becomes a relative advantage at higher doses. At the same time, Foundayo and Wegovy Pill are FDA-approved products that have been through rigorous clinical testing — a real and meaningful distinction. The right choice depends on how you weigh cost certainty against regulatory certainty.
Side Effects: What to Expect in Your First Month
Weeks 1–2
Nausea is the most common early side effect. Starting at the lowest dose and titrating slowly — which every reputable provider does — dramatically reduces severity. Most people find it manageable.
Weeks 2–4
Constipation often emerges as appetite decreases and you eat less. Fiber, hydration, and over-the-counter remedies handle this for most patients.
Weeks 4–8
Side effects typically diminish significantly. This is when most people find their stride — appetite is controlled, energy stabilizes, and the medication feels like routine.
What to watch for (rare but serious)
Severe or persistent abdominal pain (possible pancreatitis), any lump or swelling in the neck (thyroid concern). Contact your provider immediately if these occur.
Who should NOT take GLP-1 medications: Anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). History of pancreatitis: discuss risks with your prescriber.
How We Verified This Comparison
The RX Index is an independent comparison resource for GLP-1 telehealth providers. Here’s exactly what we checked.
Pricing verification — week of April 7, 2026
- Foundayo: foundayo.lilly.com/coverage-savings
- Wegovy Pill: wegovy.com/obesity/what-to-pay-for-wegovy.html
- Zepbound: zepbound.lilly.com/savings
- Ro: ro.co/weight-loss/pricing
- MEDVi: medvi.io
- Eden: tryeden.com
- Yucca: tryyucca.com/semaglutide
What we did NOT assume
- We did not assume compounded medications deliver equivalent clinical outcomes to FDA-approved products
- We did not assume advertised prices include all fees unless we verified the checkout flow
- We did not accept paid placements or let affiliate relationships influence rankings
This page is verified monthly. The “Last verified” date reflects our most recent full review. Pricing is subject to change — we update accordingly.
Frequently Asked Questions
Is compounded semaglutide still available in 2026?+
What is the cheapest alternative to compounded semaglutide?+
What is the safest alternative to compounded semaglutide?+
Can I switch from compounded semaglutide to Wegovy without restarting?+
Is the Wegovy pill cheaper than compounded semaglutide?+
What is Foundayo?+
Are compounded oral GLP-1 tablets the same as the Wegovy pill or Foundayo?+
What if my insurance won't cover weight-loss medication?+
What happens if compounded GLP-1s get fully banned?+
Are compounded GLP-1 products FDA-approved?+
What if I'm on Medicare?+
Still not sure which GLP-1 program is right for you?
Four questions. Your budget, insurance status, needle preference, and how much FDA approval matters to you. We’ll show you exactly which option fits — with current pricing and a direct link to get started. No signup required. No email gate.
Take the free 60-second GLP-1 matching quiz →Related GLP-1 Guides
Affiliate & Editorial Disclosure
The RX Index is an independent comparison resource for GLP-1 telehealth providers. This page is for informational purposes only and does not constitute medical advice. GLP-1 medications require a prescription from a licensed healthcare provider. Compounded medications are not FDA-approved as finished products. Always consult your doctor before starting any new medication. We may earn a commission if you purchase through our links, at no extra cost to you. Rankings are based on verified pricing, trust signals, and transparent disclosure — not commission rates. Pricing is subject to change — we verify monthly and update accordingly.
Last verified: | Next scheduled audit: May 2026
Related guides